We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Plasma Acid Phosphatase in Idiopathic and Secondary Thrombocytopenias

Mark H. Cooley, MD; Phin Cohen, MD
Arch Intern Med. 1967;119(4):345-354. doi:10.1001/archinte.1967.00290220095004.
Text Size: A A A
Published online


In THEIR study of 36 patients, Oski et al found the plasma acid phenylphosphatase (PAPP) value to be a reliable parameter for separating destructive from nondestructive thrombocytopenias.1 In six patients with acute idiopathic thrombocytopenic purpura (ITP) and in 13 of 15 cases of chronic ITP, elevation of PAPP was thought to reflect thrombocytolysis with release of the enzyme into the plasma. Conversely, in eight cases of hypoplastic thrombocytopenia the PAPP fell somewhat below the normal mean. With the exception of two patients with chronic ITP, the plasma enzyme values correlated well with platelet life-spans and bone marrow megakaryocyte activity. Thus, it was proposed that the PAPP value be added to the diagnostic tests used to classify the thrombocytopenias.

The present report concerns nine patients with ITP in whom an attempt was made to correlate PAPP levels with platelet counts, radioactive chromium (51Cr) platelet lifespans, and therapeutic response to


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.